4//SEC Filing
Salter Malcolm 4
Accession 0000899243-20-027692
CIK 0001662579other
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 9:26 PM ET
Size
12.2 KB
Accession
0000899243-20-027692
Insider Transaction Report
Form 4
Salter Malcolm
Director
Transactions
- Conversion
Common Stock
2020-10-06+11,856→ 11,856 total - Conversion
Common Stock
2020-10-06+2,823→ 14,679 total - Purchase
Common Stock
2020-10-06$19.00/sh+1,315$24,985→ 15,994 total - Conversion
Series A Preferred Stock
2020-10-06−100,000→ 0 total→ Common Stock (11,856 underlying) - Conversion
Series B Preferred Stock
2020-10-06−23,809→ 0 total→ Common Stock (2,823 underlying)
Footnotes (1)
- [F1]Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001825124
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 9:26 PM ET
- Size
- 12.2 KB